HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guangyan Kan Selected Research

pseudouridylate synthetase

1/2021Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guangyan Kan Research Topics

Disease

2Carcinogenesis
09/2020 - 06/2017
2Neoplasms (Cancer)
01/2020 - 06/2017
2Retinoblastoma (Glioblastoma, Retinal)
01/2020 - 06/2017
1Colorectal Neoplasms (Colorectal Cancer)
01/2021

Drug/Important Bio-Agent (IBA)

2UbiquitinIBA
01/2020 - 06/2017
1pseudouridylate synthetaseIBA
01/2021
1trametinibIBA
01/2021
1pyrazofurinIBA
01/2021
1Small Interfering RNA (siRNA)IBA
09/2020
1Histone Deacetylases (Histone Deacetylase)IBA
01/2020
1Histone Deacetylase InhibitorsIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
06/2017

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2020